Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974494-25-000030
Filing Date
2025-03-17
Accepted
2025-03-17 16:24:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3594
  Complete submission text file 0001974494-25-000030.txt   5194
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Subject) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39992 | Film No.: 25744837
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ACHILLION PHARMACEUTICALS, INC 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Di Donato Brian (Reporting) CIK: 0001766498 (see all company filings)

Type: 144